Literature DB >> 23352506

Protective effect of sanguinarine against acetic acid-induced ulcerative colitis in mice.

Xiaofeng Niu1, Ting Fan, Weifeng Li, Huimin Huang, Yanmin Zhang, Wei Xing.   

Abstract

The quaternary ammonium salt, sanguinarine (SANG), is of great practical and research interest because of its pronounced, widespread physiological effects, which promote anti-microbial and anti-inflammatory responses in experimental animals. Although SANG is originally shown to possess anti-inflammatory properties and it has been used to treat various inflammatory diseases, its effects on ulcerative colitis have not been previously explored. The aim of the present study is to evaluate the effect of SANG on acetic acid-induced ulcerative colitis in mice. Experimental animals received SANG (1, 5 and 10 mg/kg, p.o.) and sulfasalazine (500 mg/kg, p.o.) for seven consecutive days after induction of colitis by intra-rectal acetic acid (5% v/v) administration. The colonic mucosal injury was assessed by clinical, macroscopic, biochemical and histopathological examinations. SANG treatment significantly decreased mortality rate, body weight loss, disease activity index (DAI), wet colon weight, macroscopic and histological score when compared to acetic acid-induced controls. In addition, administration of SANG effectively inhibited p65 NF-κB protein expression and MPO activity accumulation. The levels of TNF-α and IL-6 in the serum and colon tissue of mice with experimental colitis were decreased by SANG in a concentration-dependent manner in response to p65 NF-κB. The possible mechanism of protection on experimental colitis was that SANG could be through attenuating early steps of inflammation as well as decreasing the expression of NF-κB and subsequent pro-inflammatory cytokines production.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23352506     DOI: 10.1016/j.taap.2013.01.009

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  21 in total

1.  Bupropion Ameliorates Acetic Acid-Induced Colitis in Rat: the Involvement of the TLR4/NF-kB Signaling Pathway.

Authors:  Amir Rashidian; Pegah Dejban; Kiana Karami Fard; Alireza Abdollahi; Mohsen Chamanara; Ahmadreza Dehpour; Amin Hasanvand
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

Review 2.  Animal models of inflammatory bowel disease: a review.

Authors:  Nidhi Goyal; Ajay Rana; Abhilasha Ahlawat; Krishna Reddy V Bijjem; Puneet Kumar
Journal:  Inflammopharmacology       Date:  2014-06-07       Impact factor: 4.473

3.  The anti-ulcerative colitis effects of Annona squamosa Linn. leaf aqueous extract in experimental animal model.

Authors:  Rasha Ym Ibrahim; Amal I Hassan; Eithar K Al-Adham
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Allicin Alleviates Dextran Sodium Sulfate- (DSS-) Induced Ulcerative Colitis in BALB/c Mice.

Authors:  Ashok Kumar Pandurangan; Salmiah Ismail; Zeinab Saadatdoust; Norhaizan Mohd Esa
Journal:  Oxid Med Cell Longev       Date:  2015-05-05       Impact factor: 6.543

5.  Molecular signatures of sanguinarine in human pancreatic cancer cells: A large scale label-free comparative proteomics approach.

Authors:  Chandra K Singh; Satwinderjeet Kaur; Jasmine George; Minakshi Nihal; Molly C Pellitteri Hahn; Cameron O Scarlett; Nihal Ahmad
Journal:  Oncotarget       Date:  2015-04-30

6.  Anticolitis activity of Chinese herbal formula yupingfeng powder via regulating colonic enterochromaffin cells and serotonin.

Authors:  Kai-hong Zang; Zhi Rao; Guo-qiang Zhang; Hong-yan Qin
Journal:  Indian J Pharmacol       Date:  2015 Nov-Dec       Impact factor: 1.200

Review 7.  Recent Trends in Pharmacological Activity of Alkaloids in Animal Colitis: Potential Use for Inflammatory Bowel Disease.

Authors:  Ana Cristina Alves de Almeida; Felipe Meira de-Faria; Ricardo José Dunder; Luis Paulo Bognoni Manzo; Alba Regina Monteiro Souza-Brito; Anderson Luiz-Ferreira
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-09       Impact factor: 2.629

Review 8.  Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?

Authors:  Fabiana Andréa Moura; Kívia Queiroz de Andrade; Juliana Célia Farias Dos Santos; Orlando Roberto Pimentel Araújo; Marília Oliveira Fonseca Goulart
Journal:  Redox Biol       Date:  2015-10-23       Impact factor: 11.799

Review 9.  A review on chemical-induced inflammatory bowel disease models in rodents.

Authors:  Puneet Kaur Randhawa; Kavinder Singh; Nirmal Singh; Amteshwar Singh Jaggi
Journal:  Korean J Physiol Pharmacol       Date:  2014-08-13       Impact factor: 2.016

10.  Effect of venlafaxine on experimental colitis in normal and reserpinised depressed rats.

Authors:  Mohsen Minaiyan; Valiollah Hajhashemi; Mohammad Rabbani; Ehsan Fattahian; Parvin Mahzouni
Journal:  Res Pharm Sci       Date:  2015 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.